MiRNA-92a protects pancreatic B-cell function by targeting KLF2 in diabetes mellitus.
CONCLUSION: Altogether, we verified the function and mechanism of miRNA-92a and provide evidence that miRNA-92a may serve a potential candidate for the clinical treatment for DM.
PMID: 29660330 [PubMed - as supplied by publisher]
Source: Biochemical and Biophysical Research communications - Category: Biochemistry Authors: Wang W, Wang J, Yan M, Jiang J, Bian A Tags: Biochem Biophys Res Commun Source Type: research
More News: Biochemistry | Diabetes | Diabetes Mellitus | Endocrinology | Environmental Health | Insulin | Pancreas | Study